Back

External validation of the ORBI risk score for cardiogenic shock prediction in patients with ST-segment elevation myocardial infarction

24 March 2023 (10:45 - 11:45)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes, cardiogenic shock and acute kidney injury Cardiogenic Shock ACVC Premium Access ESC Acute CardioVascular Care 2023 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Maya Riche

Rangueil Hospital of Toulouse, Toulouse (France)

8 More presentations in this session

Presentation thumbnail
Haemoglobin drop in patients with myocardial infarction and without previous anaemia is associated with an increased incidence of heart failure and cardiogenic shock
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides
Presentation thumbnail
Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial
Mr J. Kunkel (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Incidence rates of the different initial rhythms during out-of-hospital cardiopulmonary resuscitation and mortality of patients presenting ST elevation myocardial infarction
Doctor D. Szabo (Budapest, HU)
Abstract Slides
Presentation thumbnail
Adjusted pulse pressure associated with weaning from venoarterial extracorporeal membrane oxygenator in patients with acute myocardial infarction complicated by cardiogenic shock
Associate Professor J. Yang (Seoul, KR)
Abstract Slides
Presentation thumbnail
Therapeutic limitation in cardiogenic shock: lessons learnt from the Altshock-2 registry
Doctor V. Ditali (Brussels, BE)
Abstract Slides

Access the full session

Session thumbnail
Acute coronary syndromes, cardiogenic shock and acute kidney injury

The Event

Event poster

ESC Acute CardioVascular Care 2023

24 March 2023 10:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources